Maternal mortality is the most important indicator of womens health, but its level is still high. In 2018, 146 cases of maternal death were registered in the Russian Federation. Its main causes were extragenital diseases, bleeding, preeclampsia and eclampsia, amniotic fluid embolism, clinical narrow pelvis, and unsafe abortion. The aim of this study was to assess the structure of maternal mortality in recent years and to evaluate possible ways to reduce it. This was achieved by using an analytical method including carrying out a detailed systematic analysis of modern domestic and foreign literature on the maternal mortality issue. The study used databases such as eLIBRARY.RU, Scopus, PubMed, MEDLINE, ScienceDirect, and Cochrane Library from the creation until July 2021. The measures adopted so far do not allow for counting on a further decrease in maternal mortality rate, therefore the coming decade requires the introduction of artificial intelligence technologies.

No abstract

Imperfection of cytological diagnostics of cervical cancer has prompted the search for alternative methods of pathology detection. The aim of the study was to evaluate the effectiveness of inflammatory proteins as molecular markers in the diagnosis of cervical oncopathology.Materials and Methods. A prospective controlled trial was conducted with three groups of women: group 1 (n=13) -with precancerous pathology (cervical intraepithelial neoplasia of grade III); group 2 (n=49) -patients with cervical cancer; group 3, control (n=13)gynecologically healthy women (mean age -30.0±4.4 years).The material for the study was cervical epithelium, which was taken according to the standard technique using a cytobrush from the junction zone of cervical. The levels of inflammatory proteins (SAA, ICAM-1, VCAM-1, and sCD27) in the cervical epithelium were determined by flow cytometry.Results. Molecular criteria for the presence of precancerous pathology and cervical cancer have been found to be a 3.10 [1.31; 3.28] fold increase in SAA values (U=41.0, p=0.02), 2.62 [2.79 3.50] fold (U=137.0, p=0.001) in 5.20 [3.84; 12.37] fold (U=138.5, p=0.001) in VCAM-1, and 4.32 [2.07; 5.02] fold (U=109.0, p<0.001) in sCD27 in cervical epithelium compared with the control group data. The COP (cervical oncoproblem) coefficient was developed to calculate the probability of cervical oncological pathology presence with the accuracy of 90%. An application for Android was created in Delphi development environment to simplify its calculation. Conclusion.The created technology makes it possible to establish the diagnosis in the shortest possible time and to optimize the treatment and diagnostic process by accelerating the examination period and improving its accuracy.

Inflammatory diseases of women pelvic organs in reproductive period reach 60% among outpatients and 30% among inpatient gynecological patients. Aim. The aim of the study was to evaluate therapy effectiveness of women pelvic organs deseases with Galavit as part of combination therapy compared to standard treatment. Materials and methods. The study included 120 patients with diagnosis of inflammatory diseases of pelvic organs, randomized to 2 equal groups (n=60). In the main group, the patient in complex therapy received Galavit, according to the scheme: for 5 days, 100 mg intramuscularly 1 time per day, then 100 mg every 72 hours (No. 20); in the control group - only standard treatment. Results. Improvement of clinical condition (reduction of severity, normalization of body temperature, reduction of pain syndrome) in patients of the main group was observed 2 times faster than in patient of control group. Quickly resolve the signs of inflammation by ultrasound in the main group. The number of leukocytes, ESR, LII in the main group normalized faster than in patient of control group. On the background of treatment complications of inflammatory diseases of women pelvic organs was observed in 6 (5%) patients of the main group and 9 (7.5%) patients of the control group; aftercare of patients of the main group with ineffectiveness of therapy was achieved without tubectomy. The duration of treatment in the study group was 8±2.6 days us 10±3.9 days in the control group. Conclusion. The inclusion of Galavit in the complex therapy of inflammatory diseases of women pelvic organs accelerates relief of inflammation symptoms and reduces frequency of complications, which allows to preserve reproductive function. Galavit can be recommended for treatment inflammatory diseases of women pelvic organs.

The article provides information on immunopathology in sepsis and the commonality between immunopathogenetic processes of sepsis and the new coronavirus infection (COVID-19). As a result of the inability of the immune system to cope with aggression of the pathogen, inadequate immune activity occurs manifested by the systemic inflammatory response syndrome, resulting in damage to tissues of the host organism. In response, compensatory antiinflammatory response syndrome is activated, which is manifested by inhibition of the immune response. One of its main mechanisms is signals produced by membrane receptors and their ligands. Against the background of inability of the host organism to neutralise the pathogen, numerous pathological phenomena and complications occur leading to damage to human tissues.